KalVista Pharmaceuticals, Inc. (KALV) — Analyst estimates
Consensus analyst estimates for KalVista Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 56.39M | -0.23 | 6 |
| 2027 | 310.95M | 0.64 | 6 |
| 2028 | 425.4M | 2.02 | 3 |
| 2029 | 512.97M | 3.12 | 4 |
| 2030 | 589.46M | 3.61 | 2 |
Consensus analyst estimates by fiscal year.